Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 10Prostatic Neoplasms 8Colonic Neoplasms 7Neoplasms 5Colorectal Neoplasms 5Multiple Myeloma 4Smoldering Multiple Myeloma 3Monoclonal Gammopathy of Undetermined Significance 3Lung Neoplasms 3Uterine Cervical Neoplasms 2Uterine Cervical Dysplasia 2Stomach Neoplasms 2Rectal Neoplasms 2Radiodermatitis 2Pancreatic Neoplasms 2Pain 2Esophageal Neoplasms 2Breast Carcinoma In Situ 2Adenomatous Polyposis Coli 2cyclopia sequence 1Uterine Neoplasms 1Tuberous Sclerosis 1Thrombocythemia, Essential 1Stomatitis 1Sezary Syndrome 1Seizures 1Psychological Well-Being 1Prostate Cancer Metastatic Castration Resistant 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Sulindac 1Curcumin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Aberrant Crypt Foci × Curcumin × Clear all
NCT00176618 2009-12-11

The Effects of Curcuminoids on Aberrant Crypt Foci in the Human Colon

Rutgers, The State University of New Jersey

Phase NA Terminated
60 enrolled

Aberrant Crypt Foci

Data powered by HemOnc (CC BY 4.0) Colophon âš¡